Bavarian Nordic A/S (BVNRY)
11.04
+0.17
(+1.56%)
USD |
OTCM |
Aug 24, 16:00
Bavarian Nordic EPS Diluted (Quarterly) : 0.4995 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4995 |
| March 31, 2026 | 0.0115 |
| December 31, 2025 | -0.1983 |
| September 30, 2025 | 0.7287 |
| June 30, 2025 | 0.2358 |
| March 31, 2025 | 0.1322 |
| December 31, 2024 | 0.4677 |
| September 30, 2024 | 0.0442 |
| June 30, 2024 | 0.1608 |
| March 31, 2024 | -0.0711 |
| December 31, 2023 | 0.5648 |
| September 30, 2023 | -0.2127 |
| June 30, 2023 | 0.3362 |
| March 31, 2023 | 0.2322 |
| December 31, 2022 | 0.0969 |
| September 30, 2022 | 0.0077 |
| June 30, 2022 | -0.1607 |
| March 31, 2022 | -0.1942 |
| December 31, 2021 | -0.0802 |
| September 30, 2021 | -0.0673 |
| June 30, 2021 | -0.1272 |
| March 31, 2021 | -0.1188 |
| December 31, 2020 | -0.3898 |
| September 30, 2020 | 0.0236 |
| June 30, 2020 | 0.0938 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6193 |
| December 31, 2019 | -0.0555 |
| September 30, 2019 | -0.1207 |
| June 30, 2019 | -0.1255 |
| March 31, 2019 | -0.1239 |
| December 31, 2018 | -0.1266 |
| September 30, 2018 | 0.0404 |
| June 30, 2018 | -0.1433 |
| March 31, 2018 | -0.2481 |
| December 31, 2017 | -0.2378 |
| September 30, 2017 | 0.4248 |
| June 30, 2017 | 0.0586 |
| March 31, 2017 | -0.0076 |
| December 31, 2016 | 0.107 |
| September 30, 2016 | 0.1265 |
| June 30, 2016 | -0.036 |
| March 31, 2016 | -0.1793 |
| December 31, 2015 | 0.0039 |
| September 30, 2015 | -0.0707 |
| June 30, 2015 | 0.086 |
| March 31, 2015 | 0.0637 |
| December 31, 2014 | 0.1549 |
| September 30, 2014 | -0.0328 |
| June 30, 2014 | -0.1017 |
| March 31, 2014 | 0.0022 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Evaxion AS | -0.4464 |
| Genmab A/S | 0.4903 |
| Ascendis Pharma A/S | 3.522 |
| Zealand Pharma A/S | 8.610 |
| Agenus, Inc. | -0.0146 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 113.83M |
| Revenue (Quarterly) | 315.94M |
| Total Expenses (Quarterly) | 202.11M |
| Enterprise Value | 2.176B |
| Gross Profit Margin (Quarterly) | 60.45% |
| Profit Margin (Quarterly) | 36.03% |
| Earnings Yield | 9.43% |
| Operating Earnings Yield | 6.22% |
| Normalized Earnings Yield | 9.102 |